四环医药9月1日在港交所公告为推动人工智能技术(AI)在医疗美容产品研发领域的深度应用与产业化落地本集团已与深原质药生物科技(北京)有限公司(简称“深原质药”)签署框架协议。双方将联合成立由本集团主导的AI研发公司共同探索AI驱动的新型医美产品开发此举标志着本集团在“AI+医美”创新赛道的战略布局进入实质性阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.